Abstract
Patient-Reported Quality of Life In Elderly, Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens: Results From the Phase 3b UPFRONT Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have